Please sign in to follow a disease.
Can a beauty supplement make hair thicker? new study investigates
NCT ID NCT07520019
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This 3-month study tests two doses of a dietary supplement containing biotin, collagen, keratin, and hyaluronic acid in 40 adults aged 21-50 with self-perceived thinning hair. Participants take either a low or high dose daily, and researchers measure hair thickness and strength using scalp imaging. The goal is to see if the supplement can improve hair growth and reduce shedding.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Biotin, Collagen, Keratin, and Hyaluronic Acid dietary supplement
- What this could lead to
- If it works, this could point toward an effective over-the-counter supplement option for improving hair thickness and strength in people with temporary thinning hair.
- What could go wrong
- This is a small, early-stage trial with only 40 participants and no placebo group, so results may not be generalizable. The supplement is not a drug and effects may be modest or due to chance.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
40 people
The number who actually took part.
- Started
-
Jan 2026
- Expected to finish
-
Jun 2026
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
21 to 50 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Participants must meet all of the following criteria: 1. Adults aged 21-50 years. 2. Generally healthy, as determined by medical history, physical exam, and available laboratory results from Visit 1 (Day -1/Day 0). 3. Self-perceived thinning hair associated with diet, stress, or hormonal influences. 4. Willingness to maintain the usual hair care routine, including shampoo frequency, and consistent haircut/color during the study. 5. Willingness to take the study supplement daily as instructed. 6. Willingness to avoid major changes in diet, medications, or exercise during the study and to notify the clinic of any changes. 7. Willingness to undergo all required assessments, including physical exam, vital signs, hematology, urine pregnancy test (if applicable), scalp exam, hair photography, and completion of the Hair Shedding Diary. 8. Fitzpatrick skin types I-IV. 9. Ability and willingness to provide written informed consent. Exclusion Criteria: Participants will be excluded if they meet any of the following: 1. Known allergy or intolerance to any component of the study supplement (e.g., biotin, keratin, collagen, fish/seafood, acerola). 2. Known allergy or sensitivity to hair care products specified for use in the study. 3. Pregnant, breastfeeding, or planning to become pregnant during the study period. 4. Significant stress event (e.g., death in family, miscarriage) within the past 6 months. 5. Participation in another clinical study concurrently. 6. Initiation of hormonal therapy within the past 6 months (stable use for at least 6 months allowed). 7. Current use of light therapy for hair loss. 8. Use of minoxidil or other hair growth medications within the last 3 months. 9. Current use of biotin, keratin, collagen, or similar supplements. 10. Use of prescription medications known to affect hair growth within the last 6 months. 11. Hair disorders other than self-perceived thinning hair (e.g., alopecia areata, scarring alopecia, androgenetic alopecia, telogen effluvium). 12. Uncontrolled chronic diseases (e.g., diabetes, hypertension, thyroid disorders). Stable, well-controlled conditions may be allowed at the investigator's discretion. 13. Active hepatitis, immune deficiency, human immunodeficiency virus (HIV) infection, or autoimmune disease. 14. Active dermatologic conditions that may interfere with assessments or increase risk (e.g., severe seborrheic dermatitis, psoriasis, advanced skin cancer).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Hair thinning are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Limited Liability Company Treatment and Diagnostic Center ADONIS Plus
Kyiv, Kyiv Oblast, 02002,, Ukraine
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gummy bears for baldness? new study tests sweet solution
- Can a simple scalp serum make hair fuller? new study says maybe.
- Can stem cell particles and cooling restore thinning hair?
- Hair loss hope? supplement blend shows promise for thinning hair
- New scalp elixir aims to thicken thinning hair
- Hair loss hope? supplement tested in men, but study stopped early